Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

NCT00627458 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

403

Enrollment

INDUSTRY

Sponsor class

Conditions

Acellular Pertussis
Diphtheria
Poliomyelitis
Haemophilus Influenzae Type b
Tetanus
Hepatitis B

Interventions

BIOLOGICAL: Infanrix Hexa

Sponsor

GlaxoSmithKline